CN113358870B - Orm2蛋白在制备诊断区分前列腺癌和良性前列腺增生的试剂盒中的应用 - Google Patents
Orm2蛋白在制备诊断区分前列腺癌和良性前列腺增生的试剂盒中的应用 Download PDFInfo
- Publication number
- CN113358870B CN113358870B CN202110605554.4A CN202110605554A CN113358870B CN 113358870 B CN113358870 B CN 113358870B CN 202110605554 A CN202110605554 A CN 202110605554A CN 113358870 B CN113358870 B CN 113358870B
- Authority
- CN
- China
- Prior art keywords
- prostate cancer
- distinguishing
- benign prostatic
- prostatic hyperplasia
- orm2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/342—Prostate diseases, e.g. BPH, prostatitis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110605554.4A CN113358870B (zh) | 2021-05-31 | 2021-05-31 | Orm2蛋白在制备诊断区分前列腺癌和良性前列腺增生的试剂盒中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110605554.4A CN113358870B (zh) | 2021-05-31 | 2021-05-31 | Orm2蛋白在制备诊断区分前列腺癌和良性前列腺增生的试剂盒中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113358870A CN113358870A (zh) | 2021-09-07 |
CN113358870B true CN113358870B (zh) | 2022-04-05 |
Family
ID=77530615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110605554.4A Active CN113358870B (zh) | 2021-05-31 | 2021-05-31 | Orm2蛋白在制备诊断区分前列腺癌和良性前列腺增生的试剂盒中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113358870B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1703523A (zh) * | 2002-09-30 | 2005-11-30 | 肿瘤疗法科学股份有限公司 | 诊断前列腺癌的方法 |
CN1958611A (zh) * | 2005-10-31 | 2007-05-09 | 中资汉脉(北京)生物技术有限公司 | 血清类粘蛋白抗体及其用途 |
KR101738951B1 (ko) * | 2015-12-09 | 2017-05-23 | 경북대학교 산학협력단 | Orm2를 포함하는 신경염증성 질환의 예방 또는 치료용 조성물 |
CN110161235A (zh) * | 2019-06-26 | 2019-08-23 | 江苏省中医院 | 三种血清蛋白联合用于强直性脊柱炎诊断的用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190119636A1 (en) * | 2017-10-23 | 2019-04-25 | Poseida Therapeutics, Inc. | Modified stem cell memory t cells, methods of making and methods of using same |
-
2021
- 2021-05-31 CN CN202110605554.4A patent/CN113358870B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1703523A (zh) * | 2002-09-30 | 2005-11-30 | 肿瘤疗法科学股份有限公司 | 诊断前列腺癌的方法 |
CN1958611A (zh) * | 2005-10-31 | 2007-05-09 | 中资汉脉(北京)生物技术有限公司 | 血清类粘蛋白抗体及其用途 |
KR101738951B1 (ko) * | 2015-12-09 | 2017-05-23 | 경북대학교 산학협력단 | Orm2를 포함하는 신경염증성 질환의 예방 또는 치료용 조성물 |
CN110161235A (zh) * | 2019-06-26 | 2019-08-23 | 江苏省中医院 | 三种血清蛋白联合用于强直性脊柱炎诊断的用途 |
Non-Patent Citations (1)
Title |
---|
Abstract B41: Tumor endothelial cells as a targetable gateway that modulates access of drugs to cancer cells;Michael J. Greene等;《Cancer Research》;20180531;第78卷(第10期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN113358870A (zh) | 2021-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schwegler et al. | SELDI‐TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma | |
CA2852020C (en) | Marker genes for prostate cancer classification | |
Jeong et al. | Diagnostic values of urine CYFRA21-1, NMP22, UBC, and FDP for the detection of bladder cancer | |
CN108841954B (zh) | 生物标志物在卵巢癌评估中的应用 | |
US20140274794A1 (en) | Methods and Compositions for Diagnosis of Ovarian Cancer | |
WO2013070089A1 (en) | Method and materials for the diagnosis of prostate cancers | |
CN116879558B (zh) | 卵巢癌诊断标志物、检测试剂及检测试剂盒 | |
Basim et al. | A comparison of the circulating endocan levels between the inflammatory and malignant diseases of the same organ: The breast | |
CN109971853A (zh) | 一种与非小细胞肺癌诊断相关的分子标志物及其应用 | |
CN113777311A (zh) | 一种用于食管鳞癌辅助诊断的elisa试剂盒 | |
CN113358870B (zh) | Orm2蛋白在制备诊断区分前列腺癌和良性前列腺增生的试剂盒中的应用 | |
Wang et al. | Clinical significance of serological and urological levels of bladder cancer-specific antigen-1 (BLCA-1) in bladder cancer | |
CN116121392A (zh) | 用于胰腺囊性肿瘤诊断的方法和试剂 | |
CN113652488B (zh) | Ctsf在非小细胞肺癌脑转移疗效评价中的应用 | |
CN117054655A (zh) | Cfhr5蛋白在制备诊断区分前列腺癌和良性前列腺增生的试剂盒中的应用 | |
JP2002515263A (ja) | 前立腺がんを診断し、モニターし、そして病期決定する新規な方法 | |
CN106480188A (zh) | 转移性前列腺癌早期预测的分子探针、试剂盒及该分子探针的应用 | |
Shi et al. | Peptidome profiling of human serum of uveal melanoma patients based on magnetic bead fractionation and mass spectrometry | |
CN111413447A (zh) | 鹅去氧胆酸或/和牛磺酸鹅去氧胆酸在胆管癌诊断方面的应用 | |
CN112680514A (zh) | 一种肝癌诊断的标志物及其应用 | |
US7662582B2 (en) | Method of identifying cancer biomarkers and cancer progression | |
CN117741155A (zh) | Abcc4蛋白用于制备前列腺癌诊断试剂盒的用途 | |
CN117625790B (zh) | 用于前列腺癌诊断和预后判断的生物标志物及其应用 | |
Yahya et al. | Clinical assessment of TGFB1 and HP relative gene expression in the peripheral blood of prostate cancer patients | |
NL2027764B1 (en) | Serum protein marker set and test kit for detecting advanced schistosomiasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Ma Gaoxiang Inventor after: Ge Yuqiu Inventor after: Cui Li Inventor after: Shi Qianqian Inventor after: Jing Wentao Inventor after: OuYang Qiong Inventor after: Li Xu Inventor before: Ma Gaoxiang Inventor before: Ge Yuqiu Inventor before: Cui Li Inventor before: Shi Qianqian Inventor before: Jing Wentao Inventor before: OuYang Qiong Inventor before: Li Xu |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |